Key result
Inhibiting Hif1a with PX-478 reduces inflammatory cell infiltration in autoimmune myocarditis.
Why the study?
The immunological network across different myocarditis phases and during the transition to dilated cardiomyopathy remains unknown.
Does Hif1a inhibition with PX-478 alleviate the inflammatory response in experimental autoimmune myocarditis?
Population
Mice with experimental autoimmune myocarditis and human heart tissues from heart transplant recipients
Comparison
Different phases of experimental autoimmune myocarditis vs normal controls
Design
Preclinical single-cell RNA sequencing and translational tissue study
Authors
Loading...
Maps immune dynamics across EAM phases; leaves open whether Hif1a targeting alters human myocarditis outcomes.
Does Hif1a inhibition with PX-478 alleviate the inflammatory response in experimental autoimmune myocarditis?
Single-cell RNA sequencing reveals that Hif1a regulates the inflammatory response in autoimmune myocarditis, and its inhibition with PX-478 alleviates inflammation in a preclinical model.
Hua et al. (2020) studied Autoimmune Myocarditis. Hif1a inhibitor (PX-478) vs. Normal control / healthy control subjects was evaluated on Immunological network and cell subtypes during EAM phases. Single-cell RNA sequencing identified 26 cell subtypes in autoimmune myocarditis, revealing that Hif1a regulates inflammatory responses and its inhibition by PX-478 alleviates inflammatory cell infiltration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: